Le Lézard
Classified in: Business, Covid-19 virus
Subject: LEG

Equifax CEO Mark W. Begor Statement Of Support For Federal CARES Act


ATLANTA, March 27, 2020 /PRNewswire/ -- Equifax CEO Mark W. Begor issued the following statement of support for the passage of the Coronavirus Aid, Relief, and Economic Security (CARES) Act:

"These are uncharted waters for everyone around the world. That means every part of society - individuals as well as the public and private sector - needs to work together on creative solutions that ease the financial burden caused by this pandemic. With so much uncertainty right now, it's important to do what's right and fair to help protect Americans who may be impacted by this unfortunate situation.

The CARES Act provides more certainty for consumers by helping to protect their credit standing. We hope this gives people some reassurance so that they can focus on what is truly important - their health and that of their families and friends."

ABOUT EQUIFAX INC.

Equifax is a global data, analytics, and technology company and believes knowledge drives progress. The Company blends unique data, analytics, and technology with a passion for serving customers globally, to create insights that power decisions to move people forward. Headquartered in Atlanta, Equifax operates or has investments in 24 countries in North America, Central and South America, Europe, and the Asia Pacific region. It is a member of Standard & Poor's (S&P) 500® Index, and its common stock is traded on the New York Stock Exchange (NYSE) under the symbol EFX. Equifax employs approximately 11,000 employees worldwide. For more information, visit Equifax.com and follow the company's news on Twitter and LinkedIn.

For more information:
[email protected]

SOURCE Equifax Inc.


These press releases may also interest you

at 10:01
The Predictive Maintenance Market is estimated to grow from USD 10.6...

at 08:40
The "Global Cell Counting Market: Analysis By Product, By Application, By End-User, By Region Size, Trends and Forecast to 2029" report has been added to ResearchAndMarkets.com's offering. The global cell counting market was valued at US$9.98...

at 06:15
The "Global Immune Health Supplements Market - Outlook & Forecast 2023-2028" report has been added to  ResearchAndMarkets.com's offering. The global immune health supplements market was valued at $20.80 billion in 2022 and is expected to reach...

at 05:45
The Gross Law Firm issues the following notice to shareholders of Amplitude, Inc. . Shareholders who purchased shares of AMPL during...

at 05:45
The Gross Law Firm issues the following notice to shareholders of Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II ....

at 05:30
The "Syndromic Multiplex Panels Markets. Strategies and Trends. Forecasts by Syndrome (Respiratory, Sepsis, GI etc.) by Place, by Product and by Country. With Market Analysis and Executive Guides. 2024 to 2028" report has been added to...



News published on and distributed by: